Cancer Patient Story: Cannabis for Chemotherapy Side Effects | MarijuanaHealth
Back to Blog
Patient Story
8 min read

Cancer Patient Story: Cannabis for Chemotherapy Side Effects

Patient Testimonial December 15, 2025
"I lost 22 pounds in the first two months of chemo. I couldn't keep anything down. My oncologist was worried we'd have to pause treatment. Cannabis didn't cure my cancer — but it let me get through the treatment that did."

— Lisa K., 47, breast cancer survivor, Portland, Oregon

The Diagnosis

Lisa was 44 when she found the lump during a routine self-exam. The biopsy confirmed Stage IIB invasive ductal carcinoma — HER2-positive breast cancer. Her treatment plan was aggressive: six cycles of AC-T chemotherapy (doxorubicin, cyclophosphamide, then paclitaxel), followed by targeted therapy with trastuzumab (Herceptin) and radiation.

"My oncologist was excellent. She was honest with me about what to expect. She said the nausea would be significant, the fatigue would be profound, and I might lose my appetite entirely. She was right about all of it."

The Side Effect Crisis

The first cycle of AC chemotherapy hit Lisa harder than anticipated. Standard antiemetics — ondansetron (Zofran) and dexamethasone — provided partial relief but couldn't fully control the nausea. She was vomiting multiple times daily for the first week after each infusion. Food became repulsive. She lost 22 pounds in eight weeks.

"I remember sitting at the dinner table trying to eat a piece of toast and just crying. Not because I was sad — I was determined to fight — but because I physically couldn't make myself eat. My body was rejecting everything."

At her six-week check-in, her oncologist raised the possibility of pausing chemotherapy to allow recovery. "That scared me more than anything. I didn't want to give the cancer any time to regroup. I needed to get through this."

The Conversation with Her Oncologist

Lisa had heard about cannabis from another patient in her infusion center — a woman who had used it during her own chemotherapy two years earlier. She brought it up with her oncologist directly.

"I was nervous to ask. I thought she might dismiss it or be judgmental. But she was completely matter-of-fact about it. She said, 'I have patients who find it helpful for nausea and appetite. There are FDA-approved cannabinoid medications for exactly this purpose. Let's talk about it.'"

Her oncologist reviewed her current medications for interactions — particularly important given that some cannabinoids can affect the metabolism of chemotherapy drugs. She determined that cannabis was safe to use alongside Lisa's specific regimen and provided a referral to a cannabis-knowledgeable physician for dosing guidance.

Finding the Right Protocol

The cannabis physician recommended a structured approach: CBD-dominant tincture (25mg CBD, 2.5mg THC) three times daily for baseline anxiety and nausea, with a higher-THC option (5mg THC, 10mg CBD) available for acute nausea episodes and appetite stimulation before meals.

"The first time I used the higher-THC product before dinner, I actually felt hungry for the first time in weeks. I ate half a plate of pasta. My husband cried. I cried. It sounds small, but it felt enormous."

Over the following weeks, Lisa developed a routine: CBD tincture in the morning and afternoon for baseline nausea control, THC-containing product 30 minutes before her two main meals to stimulate appetite, and a higher dose on the days immediately following infusions when nausea was worst.

Through the Rest of Treatment

Lisa completed all six chemotherapy cycles. She regained 14 of the 22 pounds she had lost. Her oncologist was able to maintain the full treatment schedule without pauses. The cannabis didn't eliminate the nausea — "nothing did, completely" — but it reduced it to a manageable level and, crucially, restored her ability to eat.

She also found unexpected benefits: "The anxiety was almost as bad as the physical symptoms. Lying awake at 3 a.m. wondering if the treatment was working, if the cancer had spread. The CBD helped with that. I could sleep. I could think more clearly during the day."

Pain from peripheral neuropathy — a common side effect of paclitaxel — was also partially managed with cannabis. "My feet and hands were numb and painful at the same time. The cannabis took the edge off enough that I could walk normally most days."

Two Years Later

Lisa completed her treatment in early 2024. Her most recent scans show no evidence of disease. She no longer uses cannabis regularly — "I don't need it the same way" — but keeps a CBD tincture on hand for anxiety and occasional sleep issues.

She now volunteers with a cancer patient support organization and frequently speaks with newly diagnosed patients about integrative approaches to managing treatment side effects. "I always tell them: talk to your oncologist first. Don't hide it. Cannabis isn't magic, and it's not for everyone. But for me, it was the difference between getting through treatment and not."

Medical Context: Cannabis for Chemotherapy-Induced Nausea

Lisa's experience is supported by substantial clinical evidence. The FDA approved dronabinol (synthetic THC) and nabilone for chemotherapy-induced nausea and vomiting (CINV) in 1985 and 1986 respectively — making cannabinoids among the earliest approved antiemetics. A 2015 Cochrane review of 23 randomized trials found cannabinoids were more effective than conventional antiemetics for CINV, though with more side effects. The American Society of Clinical Oncology (ASCO) guidelines acknowledge cannabis as a potential option for refractory CINV. Appetite stimulation (the "munchies") is a well-documented CB1-mediated effect with direct clinical utility in cancer cachexia. Always discuss with your oncology team — some cannabinoids can affect chemotherapy drug metabolism.